Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

IRL-3630: a bifunctional ET antagonist for respiratory ailments

May 12, 1998

Comparative studies of L-0066 in animal models of allergic bronchial inflammation

May 11, 1998

Levalbuterol shows improved therapeutic ratio over racemic albuterol

May 8, 1998

P&U reports antiasthma agent with a novel mechanism of action

May 8, 1998

Profile of BIIC-1996, a novel dual NK1/NK2 antagonist for respiratory indications

May 8, 1998

Manganic porphyrins for treatment of hyperoxic lung injury

May 8, 1998

New GABA-B antagonist shows memory-enhancing effects in rats

May 8, 1998

5-HT antibodies for treatment of alcoholism

May 8, 1998

Anxiolytic and antidepressant effects of L-701324, a glycine receptor antagonist

May 8, 1998

E-4010: a potential new treatment for pulmonary hypertension

May 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...